Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Label Placebo in TJA
NCT04883983Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2023
- Primary completion
- Sep 2024
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Visual Analogue Scale at 12 weeks, Short Form Health Survey SF-36 at 12 weeks and 2 more. Planned start Dec 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT04883983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883983.